Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;20(3):679-86.
doi: 10.1007/s10461-015-1197-5.

Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV

Affiliations

Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV

William C Becker et al. AIDS Behav. 2016 Mar.

Erratum in

Abstract

Harms of opioid analgesics, especially high-dose therapy among individuals with comorbidities and older age, are increasingly recognized. However, trends in opioid receipt among HIV-infected patients are not well characterized. We examined trends, from 1999 to 2010, in any and high-dose (≥120 mg/day) opioid receipt among patients with and without HIV, by age strata, controlling for demographic and clinical correlates. Of 127,216 patients, 64 % received at least one opioid prescription. Opioid receipt increased substantially among HIV-infected and uninfected patients over the study; high-dose therapy was more prevalent among HIV-infected patients. Trends in high-dose receipt stratified by three age groups revealed an increasing trend in each age strata, higher among HIV-infected patients. Correlates of any opioid receipt included HIV, PTSD and major depression. Correlates of high-dose receipt included HIV, PTSD, major depression and drug use disorders. These findings suggest a need for appropriate balance of risks and benefits, especially as these populations age.

Keywords: Aging; Analgesics; Chronic; Human immunodeficiency virus; Opioids; Pain.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Trends in any opioid receipt, overall and by HIV status
Fig. 2
Fig. 2
Trends in high-dose opioid receipt, overall and by HIV status (asterisk)
Fig. 3
Fig. 3
a High-dose opioid receipt by HIV status, age <45. b High-dose opioid receipt by HIV status, age 45–64. c High-dose opioid receipt by HIV status, age ≥ 65

References

    1. Drug Enforcement Administration. [Accessed 12 July 2010];Retail Drug Summary. 2010 http://www.deadiversion.usdoj.gov/arcos/retail_drug_summary/
    1. Sullivan MD, Edlund MJ, Fan M-Y, DeVries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and medicaid insurance plans: the TROUP study. Pain. 2008;138(2):440–9. - PMC - PubMed
    1. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006;7(4):225–35. - PubMed
    1. Paulozzi LJ Centers for Disease Control and Prevention. Drug-induced deaths—United States, 2003–2007. Morb Mortal Wkly Rep Surveill Summ. 2011;60(Suppl):60–1. - PubMed
    1. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief. 2009;22:1–8. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources